7
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Percutaneous Estrogen Therapy

Endometrial Response And Metabolic Effects

Pages 4-30 | Published online: 09 Jul 2009

References

  • Aergeerts J. Influence d'un traitement oestrogène sur la peau de femmes menopauses ou castrées. Brux Med 1972; 52: 215
  • Anderson D. C. Sex hormone binding globulin. Clin Endocrinol 1974; 3: 69
  • Aten R. F., Weinberger M., Eisenfeld A. J. Estrogen receptor in rat liver: Translocation to the nucleus in vivo. Endocrinology 1978; 102: 433
  • Aylward M., Maddock J., Rees P. L. Natural oestrogen replacement therapy and blood clotting. Br Med J 1976; i: 220
  • Baird D. T., Guevara A. Concentration of unconjugated estrone and estradiol in peripheral plasma in non-pregnant women throughout the menstrual cycle, castrate and postmenopausal women and in men. J Clin Endocrinol Metab 1969; 29: 149
  • Basdevant A., de Lignières B. Treatment of menopause by topical administration of oestradiol. Percutaneous Absorption of Steroids, P. Mauvais-Jarvis, C. F.H. Vickers, J. Wepierre. Academic Press, London 1980; 249–258
  • Beckman L., von Schoultz B., Stigbrand T. “Pregnancy zone” protein in sera from patients with prostatic cancer treated with oestrogens. Urol Res 1973; 1: 67
  • Beral V. Mortality among oral contraceptive users. Lancet 1977; ii: 727
  • Bolton C. H. The effect of ethinyl oestradiol and conjugated equine oestrogens on plasma lipids in oophorectomised women. The Management of the Menopause and Postmenopausal Years, S. Campbell. MTP Press, LancasterEngland 1976; 185–194
  • The Boston Collaborative Drug Surveillance Program: Surgically confirmed gallbladder disease, venous thromboembolism and breast tumors in relation to postmenopausal estrogen therapy. New Engl J Med 1974; 290: 15
  • Carlström K., Sköldefors H. Determination of total oestrone in peripheral serum from nonpregnant humans. J Steroid Biochem 1977; 8: 1127
  • , et al. JAMA 1973; 226: 652
  • Crane, Harris M. G.J.J., Winsor I W., II. Hypertension, oral contraceptive agents, and conjugated estrogens. Ann Intern Med 1971; 74: 13
  • Damber M.-G., von Schoultz B., Stigbrand T., Carlström K. A radioimmunoassay for the pregnancy zone protein. Clin Chim Acta 1976; 66: 85
  • Damber M.-G., von Schoultz, Stigbrand B., Carlstr T., öm K., Furuhjelm M. Basic levels of the immuno-suppressive serum protein PZ in women - influence of age, parity, gonadotropins and estrogens. Acta Obstet Gynecol Scand 1977; 56: 95
  • Damber M., Sandstr G., öm B., von Schoultz B., Stigbrand T. A new and sensitive method for quantifying and comparing the biological potency of various estrogens in man. Acta Obstet Gynecol Scand 1979; 58: 327
  • Ehara, Siler Y. T.N., Yen S. S.C. Effects of large doses of estrogen on prolactin and growth hormone release. Am J Obstet Gynecol 1976; 125: 455
  • Elkik, Gompel F., Mercier-Bodard A., Kutten C., Guyenne F., Corvol P. N.P., Mauvais-Jarvis P. Effects of percutaneous estradiol and conjugated estrogens on the level of plasma proteins and triglycerides in postmenopausal women. Am J Obstet Gynecol 1982; 143: 888
  • Eller J. J., Eller W. D. Estrogenic ointments; cutaneous effects of topical applications of natural estrogens, with report of 321 biopsies. Arch Dermat &Syph 1949; 59: 449
  • Makhzangy E, Wynn M. N.V., Lawrence D. M. Sex hormone binding globulin capacity as an index of oestrogenicity or androgenicity in women on oral contraceptive steroids. Clin Endocrinol 1979; 10: 39
  • Englund D. E., Johansson E. D.B. Plasma levels of oestrone, oestradiol and gonadotrophins in postmenopausal women after oral and vaginal administration of conjugated equine oestrogens (Premarin). Br J Obstet Gynaecol 1978; 85: 957
  • Fåhraeus L. Estrogens, progestogens and plasma lipo-proteins. Linköping University Medical Dissertations, LinköpingSweden 1982, No 134
  • Gambrell R. D. The menopause: Benefits and risks of estrogen-progestogen replacement therapy. Fertil Steril 1982; 37: 457
  • Geola F., Frumar L., Tataryn A. M., Lu I. V., Hersham K. H., Eggena J. M., Sambhi P. M.H., Judd H. L. Biological effects of various doses of conjugated equine estrogens in postmenopausal women. J Clin Endocrinol Metab 1980; 51: 620
  • Goldzieher J. W., Baker R. E. The percutaneous absorption of estradiol-17β and progesterone. J Invest Derm 1960; 35: 215
  • Gordon, Kannel T., Hjortland W. B.M.C. Menopause and coronary heart disease. Ann Intern Med 1978; 89: 157
  • Hammond C. B., Mason W. S. Current status of estrogen therapy of the menopause. Fertil Steril 1982; 37: 5
  • Hasselquist M., Goldberg B., Schroeter N. A., Spelsberg T. C. Isolation and characterization of the estrogen receptor in human skin. J Clin Endocrinol Me-tab 1980; 50: 76
  • Hawkins R. A., Oakey R. E. Estimation of estrone sulphate, estradiol-17β and estrone in peripheral plasma. Concentrations during the menstrual cycle and in men. J Endocrinol 1974; 60: 3
  • Helgason, Carlstr S., öm, Damber K. M.-G., von Schoultz B. Gonadotropins and prolactin during estrogen replacement therapy. Acta Obstet Gynecol Scand 1981; 60: 515
  • Helgason, Wilking S., Carlström N., Damber K. M.A., von Schoultz B. A comparative study on the estrogenic effects of tamoxifen and estradiol-17β in postmenopausal women. J Clin Endocrinol Metab 1982; 54: 404
  • Helgason, Damber S. M.-G., von Schoultz B., Stigbrand T. Estrogenic potency of oral replacement therapy estimated by the induction of pregnancy zone protein. Acta Obstet Gynecol Scand 1982; 61: 75
  • Helgason, Damber S., Damber J.-E. MA., von Schoultz B., Selstam G., Södergärd R. A comparative longitudinal study on sex hormone binding globulin capacity during estrogen therapy. Acta Obstet Gynecol Scand 1982; 61: 97
  • Helgason S. Estrogen replacement therapy after the menopause. Estrogenicity and metabolic effects. Acta Obstet Gynecol Scand 1982, Suppl 107
  • Hirvonen E., Malkonen M., Manninen V. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy. N Engl J Med 1981; 304: 560
  • Howard R. P., Keaty E. C. Evaluation of equilin 3-mono-sulphate and other estrogens. Arch Intern Med 1971; 128: 229
  • Hunter W. H., Greenwood F. C. Preparation of iodine-131-labelled human growth hormone of high specific activity. Nature 1962; 194: 495
  • James, Marty M. J.P., Wepierre J. Diffusion localisée des substances absorbées par voie percutanée. C R Acad Sc Paris 1974; 278: 2063
  • Johannesson A., Hammar H. Measurements of the horny layer turnover after staining with dansyl chloride: description of a new method. Acta Dermatovener 1978; 58: 76
  • Johannison, Parker E., Landgren R. A.B.-M., Diczfalusy E. Morphometric analysis of the human en-dometrium in relation to peripheral hormone levels. Fertil Steril 1982; 38: 564
  • Judd H., Cleary L., Creasman R. E., Figge W. T., Kase D. C., Rosenwaks N. Z., Tagatz G. E. Estrogen replacement therapy. Obstet Gynecol 1981; 58: 267
  • Kandeel, Butt F. W.R., London D. R. Regulation of serum prolactin levels by oestrone and oestrone sulphate in normally menstruating women. Acta Endocrinol 85, Suppl 1977; 212: 42
  • King, Dyer R. J.B., Collins G. W.P., Whitehead M. I. Intracellular estradiol, estrone and estrogen receptor levels in endometria from postmenopausal women receiving estrogens and progestins. J Steroid Biochem 1980; 13: 377
  • King, Whitehead R. J.B., Campbell M. I.S., Minardi J. Effect of estrogens and progestinic treatment on endometrium from post-menopausal women. Cancer Res 1979; 39: 1094
  • Kohorn E. J., Thao R. The effect of hormones on endometrial carcinoma in organ culture. J Obstet Gynaecol Br Commonw 1968; 75: 1262
  • Korenman S. G. Oestrogen window hypothesis of the aetiology of breast cancer. Lancet 1980; i: 700
  • Kupperman, Wetchler H. S.B.B., Blatt N. H.G. Contemporary therapy of the menopausal syndrome. JAMA 1959; 171: 1677
  • La Groua Weill-Hallé M.-A. Estrogénotherapie percutanée de la ménopause. Rev Franc Gynéc 1977; 72: 283
  • Larsson-Cohn U., Wallentin L. Metabolic and hormonal effects of postmenopausal oestrogen replacement treatment. I. Glucose, insulin and human growth hormone levels during oral glucose tolerance tests. Acta Endocrinol (Copenh) 1977; 86: 583
  • Laurell C. B., Rannevik G. Comparison of plasma protein changes induced by danazol, pregnancy and estrogen. J Clin Endocrinol Metab 1979; 49: 719
  • Lindberg B., Lindberg S., Martinsson P. K., Johansson E. D.B. Radioimmunological methods for the estimation of oestrone, oestradiol-17β and oestriol in pregnancy plasma. Acta Obstet Gynecol Scand 1974, Suppl 32
  • Lyrenäs, Carlstr S., öm K., Bäckström T., von Schoultz B. A comparison of serum oestrogen levels after percutaneous and oral administration of oestradiol-17β. Br J Obstet Gynaecol 1981; 88: 181
  • Mandel F., Geola P., Lu F. L., Eggena J. K.H., Sambhi P., Hearshman M. P.J.M., Judd H. L. Biologic effects of various doses of ethinyl estradiol in postmenopausal women. Obstet Gynecol 1982; 59: 673
  • Mann J., Vessey I., Thorgood M. P.M., Doll R. Myocardial infarction in young women with special reference to oral contraceptive practice. Br Med J 1975; ii: 41
  • March C., Marrs M., Goebelsman R. P.U., Mishell D. R. Feedback effects of estradiol and progesterone upon gonadotropin and prolactin release. Obstet Gynecol 1981; 58: 10
  • Mishell D., Moore R., Roy D. E., Brenner S. P.F., Page M. A. Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol and d-norgestrel. Am J Obstet Gynecol 1978; 130: 55
  • Nimrod A., Ryan K. J. Aromatization of androgens by human abdominal and breast fat tissue. J Clin Endocrinol Metab 1975; 40: 367
  • Notelovitz M. Metabolic effects of conjugated oestrogens on glucose tolerance. S Afr Med J 1974; 48: 2599
  • Noyes, Hertig R. W.A.T., Rock J. Dating the endometrial biopsy. Fertil Steril 1950; 1: 3
  • Nunez, Rebourchet E. A.M.C., Jayle M. F. Pénétration de l'estradiol-17-beta-6-7-3H àtravers le tissu cutané de la ratte. Cinétique et conditions de la pénétration dans l'organisme. Bull Soc Chim Biol 1969; 51: 299
  • Ottosson U., Damber B., Damber J.-E. M., Selstam G., Solheim G., Stigbrand F. T., Södergård R., von Schoultz B. Effects on sex hormone binding globulin capacity and pregnancy zone protein of treatment with combinations of ethinyloestradiol and norethisterone. Maturitas 1981; 3: 295
  • Pasetto N., Piccione E., Pasetto F. Treatment of patients with risks. Crossover study between natural estrogens. The Menopause and Postmenopause, N. Pasetto, R. Paoletti, J. Ambrus. MTP Press, LancasterEngland 1980; 141
  • Pfeffer R., Whipple I., Kurosaki G. H.T.T., et al. Coronary risk and estrogen use in postmenopausal women. Am J Epidemiol 1978; 107: 479
  • Pogmore J. R., Jequier A. M. Sex hormone binding globulin capacity and postmenopausal hormone replacement therapy. Br J Obstet Gynaecol 1979; 86: 568
  • Poller, Thomson L. J.M., Coope J. Conjugated equine oestrogens and blood clotting: A follow-up report. Br Med J 1977; i: 935
  • Punnonen R. Effect of castration and peroral estrogen therapy on the skin. Acta Obstet Gynaecol 1973, Suppl 21
  • Quigley M. M., Hammond C. B. Estrogen-replacement therapy. Help or or hazard? N Engl J Med 1979; 301: 646
  • Rodkey F. L. Direct spectrophotometric determination of albumin in human serum. Clin Chim Acta 1965; 11: 478
  • Rosenberg L., Armstrong B., Jick H. Myocardial infarction and estrogen therapy in postmenopausal women. N Engl J Med 1976; 294: 1256
  • Ross R., Paganini-Hill K., Mack A., Arthur T. M.M., Henderson P. T. Menopausal estrogen therapy and protection from death from ischaemic heart disease. Lancet 1981; i: 858
  • Ross R., Paganini-Hill K., Gerkins A., Mack V. R., Pfeffer T. M., Arthur R. M., Henderson P.-T. A case-control study of menopausal estrogen therapy and breast cancer. JAMA 1980; 243: 1635
  • Ryan K. J., Engel L. L. The interconversion of estrone and estradiol by human tissue slices. Endocrinology 1953; 52: 287
  • Scheuplein R., Blank J., Brauner I. H.G.J., MacFarlane D. J. Percutaneous absorption of steroids. J Invest Derm 1969; 52: 63
  • Scheuplein R. J. Mechanism of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration. J Invest Derm 1967; 48: 79
  • Scheuplein R. J., Morgan L. G. “Bound water” in keratin membranes measured by a microbalance technique. Nature 1967; 214: 456
  • Scheuplein R. J. Percutaneous absorption: theoretical aspects. Percutaneous Absorption of steroids, P. Mauvais-Jarvis, C. F.H. Vickers, J. Wepierre. Academic Press, London 1980; 1–17
  • Shahrad P., Marks R. A pharmacological effect of oestrone on human epidermis. Brit J Derm 1977; 97: 383
  • Shanbhag V. P., Södergärd R., Carstensen H., Albertssonå P. A new method for the determination of the binding capacity of testosterone-estradiol-binding globulin in human plasma. J Steroid Biochem 1973; 4: 537
  • Siiteri, Schwarz P. K.B.E., MacDonald P. C. Estrogen receptors and the estrone hypothesis in relation to endometrial and breast cancer. Gynecol Invest 1974; 2: 228
  • Spellacy, Buhi W. H.W.B., Burk S. A. The effect of estrogens on carbohydrate metabolism: glucose, insulin and growth hormone studies on 171 women ingesting premarin, mestranol and ethinylestradiol for six months. Am J Obstet Gynecol 1972; 114: 378
  • Speroff, Glass L. R.H., Kase N. G. Clinical Gynecologic Endocrinology and Infertility. 2nd edition. The Williams &Wilkins Co, Baltimore 1978
  • Studd, Thom J. W.W., Paterson M. H.M.E.L., Wade-Evans T. The prevention and treatment of endometrial pathology in postmenopausal women receiving exogenous oestrogens. The Menopause and the Postmenopause, N. Pasetto, R. Paoletti, J. L. Ambrus. MTP Press, London 1980; 122
  • Sunderman F. W., Nomoto S. Measurement of human serum ceruloplasmin by its p-phenylenediamine oxidase activity. Clin Chem 1970; 16: 903
  • Södergård R., Bäckström T., Shanbhag V., Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma proteins at body temperature. J Steroid Biochem 1982; 16: 801
  • Teisner, Lange B., Folkersen A. P., Anthonsen J. H., von Schoultz B., Stigbrand T. Serum levels of the “pregnancy zone protein” during short-term prenatal dexamethasone therapy. Acta Obstet Gynecol Scand 1981; 60: 161
  • Thom, Chakravarti M., Oram S. D.H., Studd J. W.W. Effect of hormone replacement therapy on glucose tolerance in postmenopausal women. Br J Obstet Gynaecol 1977; 84: 776
  • Weibel E. R. Stereological methods, vol. 1: Practical methods for biological morphometry. Academic Press, London 1979
  • Wentz W. B. Effect of a progestational agent on endometrial hyperplasia and endometrial cancer. Obstet Gynaecol 1964; 24: 370
  • Vermulen A. The hormonal activity of the postmenopausal ovary. J Clin Endocrinol Metab 1976; 42: 247
  • Vessey M., Mc P., Pherson K., Johnson B. Mortality among women participating in the Oxford Family Planning Association Contraceptive Study. Lancet 1977; ii: 731
  • Whitehead M., Lane I., Dyer G., Townsend G., Collins P. T.W.P., King R. B. J. Oestradiol: The predominant intranuclear oestrogen in the endometrium of oestrogentreated postmenopausal women. Br J Obstet Gynaecol 1981; 88: 914
  • Whitehead M., Townsend I., Kitchin P. T., Dyer Y., Igbal G., Mansfield M. J., Young M. D.O., Minardi J. Plasma steroid and protein hormone profiles in postmenopausal women following topical administration of oestradiol-17β. Percutaneous Absorption of Steroids, P. Mauvais-Jarvis, C. F.H. Vickers, J. Wepierre. Academic Press, London 1980; 231–248
  • Whitehead M., Townsend I., Pryse-Davis P. T., Ryder J., Lane T., Siddle G. N.G., King R. J.B. Effects of various types and dosages of progestogens on the postmenopausal endometrium. J Reprod Med 1982; 27: 339
  • Whitehead M., Mc I., Queen J., Minardi J., Campbell S. Progestogen modification of estrogen-induced endometrial proliferation in climacteric women. The Menopause and Postmenopause, N. Pasetto, R. Paoletti, J. L. Ambrus. MTP Press Ltd, LancasterEngland 1980; 31
  • Widholm O., Vartiainen E. The absorption of conjugated oestrogen and sodium oestrone sulphate from the vagina. Ann Chir Gynaecol 1977; 63: 186
  • Vigersky R., Kono A., Sauer S., Lipsett M. M.B., Loriaux D. L. Relative binding of testosterone and estradiol to testosterone-estradiol binding globulin. J Clin Endocrinol Metab 1979; 49: 899
  • Yen S. S.C., Vela P. Effects of contraceptive steroids on carbohydrate metabolism. J Clin Endocrinol Metab 1968; 28: 1564
  • Yen S. S.C. The biology of menopause. J Reprod Med 1977; 18: 281
  • Yen, Martin S. S.C., Burnier P. L., Czekala A. M., Greany N. M.M.O.J., Callantine M. R. Circulating estradiol, estrone and gonadotropin levels following the administration of orally active 17β-estradiol in postmenopausal women. J Clin Endocrinol Metab 1915; 40: 518
  • Zondek B. Folliculin. Klin Wschr 1929; 8: 2229

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.